"&#xa0;\n&#xa0;\n               Written evidence submitted by the Human Tissue Authority (BTO0032)&#xa0;Introduction \n&#xa0;&#xa0;\n&#xa0;About the HTA\n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\nHTA’s role in ensuring the quality and safety of cells, tissue and organs\n&#xa0;&#xa0;Ensuring the quality and safety of human tissue and cells used for the treatment of patients&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;Selection criteria for deceased donors of tissues and/or cells \n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\nSelection criteria for living donors of tissues and/or cells \n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\nThe HTA inspection process\n&#xa0;\n&#xa0;\nEnsuring the quality and safety of organs intended for transplantation &#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;Reporting and investigating serious adverse events and reactions &#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;Supporting effective research&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\nChecking the knowledge and understanding of living donors&#xa0;\n&#xa0;Collaborative working and support for the sector &#xa0;\n&#xa0;\n&#xa0;Conclusions and recommendations\n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\n&#xa0;\nJanuary 2014\n&#xa0;\n&#xa0;&#xa0;\n&#xa0;\n"